General Aspects of Antibacterial Resistance Surveillance Hajo Grundmann University Medical Centre Groningen ReAct – Action on Antibiotic Resistance.

Slides:



Advertisements
Similar presentations
Surveillance of nosocomial infections Johnny, Courtesy, Brocolli.
Advertisements

Surveillance of antimicrobial resistance Liselotte Högberg Swedish Institute for Infectious Disease Control
Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.
Susceptibility Testing Anaerobes
British Society for Antimicrobial Chemotherapy Symposium Resistance and treatment issues in Blood Stream Infection: S.aureus Alasdair MacGowan BCARE University.
Hugo McClean, Chair BASHH National Audit Group. Background to HQIP NCAPOP audits Current BASHH/MedFASH & BHIVA proposals Development to support new joint.
Module 4: Final Case Study # 4-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 4-CS-2.
Scottish Infection Research Network Research Consortia.
BALANCING EFFICIENCY AND EQUITY A NEW INTERNATIONAL RESEARCH PROGRAMME ADDRESSING THE ROLE OF VALUES IN HEALTH CARE Department of Primary Care and Public.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Role of the laboratory in disease surveillance
Unit 5: Core Elements of HIV/AIDS Surveillance
Antimicrobial resistance surveillance in Ireland Results of invasive Pseudomonas aeruginosa infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
The CAPHC Paediatric Trigger Tool
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.
Knowledge Driven Care – Realised Through Transformation Dr Simon Wallace Medical Executive Cerner UK.
Epidemiology.
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Antimicrobial resistance surveillance in Ireland Results of invasive Escherichia coli infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
European Society of Cardiology Cardiovascular diseases in women.
Ecdc.europa.eu Tommi Asikainen, Tubingen, 22 October 2008 European Centre for Disease Prevention and Control FUTURE DISEASE CHALLENGES IN EUROPE – where.
Introduction to Proposed Standards Global Surveillance of AMR in Humans Jean B. Patel, PhD, D(ABMM) WHO Collaborating Centre for International Monitoring.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Nosocomial infections. Definition Nosocomial or hospital infection  is an infection contracted in a health institution.  was not present at the patient's.
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
MLAB Microbiology Keri Brophy-Martinez Public Health & The Microbiology Lab.
WISCONSIN STATE LABORATORY OF HYGIENE 1 Analysis and Comparison of Cumulative Statewide Antibiograms for Wisconsin, 2006 and 2008 Christina M. Carlson.
Methodological challenges for AMR surveillance programmes Gous AGS, Pochee E School of Pharmacy Medical University of Southern Africa.
The Rational Use of Antibiotics
1 Evaluation of Patient-Centered Medical Home (PCMH) Initiatives Meredith B. Rosenthal, PhD February 24, 2009.
Health Technology Assessment
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.
Practical Considerations for Allied Health Professionals
Antibiotics have saved millions of lives Antibiotics are losing their effect.
Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Using AMR surveillance for developing policy AMR meeting Washington 13 April 2016.
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
October 4, 2004 Building Steps for Canada’s New Integrated Enteric Pathogen Surveillance Program 12th Annual APHEO Conference October 4, 2004 Niagara Falls,
Antimicrobial Stewardship
Research on Antimicrobial Resistance
Etiology of bacteremia in children under 5 years in Southern Mali
WHO Operational Plan for RSV Surveillance Pilot
Critical Care Services Pharmacist Royal Manchester Children’s Hospital
Title of the Change Project
Outbreak Investigations
Mary Alexander, MA, RN, CRNI®, CAE, FAAN Chief Executive Officer
Cascade of care for persons newly diagnosed
Professor Alan Johnson Department of HCAI & AMR
Evidence-Based Medicine
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Call topic identification for 2019 call
Antiretroviral therapy coverage in sub-Saharan Africa,
SUPERBUGS: STRUMENTI DI INTERVENTO NELL’ERA POST-ANTIBIOTICA
Antibiograms: “What and Why?”
ECDC point prevalence survey (PPS)
“An overview” 10th April 2018 at MOH SMT Now 27th April 2018 at NPHIL
International studY iN collaboration with WHO September 2017
Point prevalence survey epidemiology
Introduction to public health surveillance
Pharmacy practice and the healthcare system Ola Ali Nassr
Variant Triaging and ESMO Guidelines
Level of Evidence Lecture 4.
Aparna Raychaudhuri, Ph. D
Presentation transcript:

General Aspects of Antibacterial Resistance Surveillance Hajo Grundmann University Medical Centre Groningen ReAct – Action on Antibiotic Resistance

Topics Surveillance: general considerations The three levels of ABR surveillance Threats to validity and solutions

General considerations

Definition: Surveillance ‘ The ongoing systematic collection, analysis of health data essential to the planning, implementation, and evaluation, of public health practice, … Alexander Langmuir 1963

The ecological landscapes of AMR surveillance Patients Antibiotic Exposure Microbiota

The Nemesis of good surveillance in Antibiotic resistance Ambition Perfection Conflicting demands

The Demands: who defines them? Stakeholders Individuals who are directly affected Individuals who indirectly suffer from the repercussions of adverse health care outcomes caused by ABR Individuals who have a professional, corporate or altruistic responsibility

The three levels of ABR surveillance macro meta micro patient population pathogen

Patient level surveillance

Objective Optimising empirical antibiotic therapy Scale and Scope Local (single institution), timely, syndrome-based, inclusive Metric (operational unit of surveillance) Proportion resistance per infection and antibiotic compound based on the resistance among the causative pathogens (stratified by ethological fraction) see drug effectiveness index Ciccolini et al. JAC (2014)

Population level surveillance

Objective Estimating the size of ABR as a national and international public health problem Scale and Scope laboratory-based passive surveillance at selected sentinel sites using routinely available data Metric (operational unit of surveillance) Proportion resistance per indicator pathogen and antibiotic class for primary bacterial isolates (SPY criteria) from defined anatomical sites

EARSS Laboratories 1587 Hospitals >100 million citizens 33 countries

EARSS- database

EARSS- database

Pathogen level surveillance

Objective Identifying the orgin, emergence and transmission of bacterial pathogens and their high risk clones (HiRiCs) Scale and Scope laboratory-based genomic analysis of bacterial isolates Metric (operational unit of surveillance) measure of the genetic distance between any two bacterial isolates determined by high resolution genomic analysis

Threats to validity and solutions

Representativeness How many sites do you need to include to determine ABR at national level? Data quality How do you make sure that you could trust the data?

How many sites do you need to include ?

The HCU network

The “greedy” network Ciccolini et al, PNAS (2014)

How do you make sure that you can trust the data? Sentinel laboratories must adhere to agreed laboratory protocols incl. quality control, use agreed clinical susceptibility breakpoints (CLSI or EUCAST) have in place an acceptable laboratory information management system (WHO-NET) have a dedicated data manager participate in national/international quality assessment schemes (EQA)

How do you make sure that you can trust the data? ask every sentinel laboratory to perform whole genome sequencing on all indicator isolates! S. aureus AST results against Gold Standard in single laboratory

Thanks UMCG Mariano Ciccolini Tjibbe Donker ECDC Liselotte Hornberg Diaz Ole Heuer Sanger Centre Matt Holden David Aanensen EUCAST Development Laboratory,Växjö, Sweden Jenny Ahmann Erika Matuscheck Gunnar Kahlmeter United Kingdom Clinical Research Collaboration (UK CRC)